A Comprehensive Framework to Optimize Short-Term Experiences in Global Health (STEGH)

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 24 Nov 2018]

Debate  Open Access
A Comprehensive Framework to Optimize Short-Term Experiences in Global Health (STEGH)
Shivani Shah, Henry C. Lin and Lawrence C. Loh
Globalization and Health201915:27
https://doi.org/10.1186/s12992-019-0469-7
Abstract
Increasing demand for Short-term Experiences in Global Health (STEGH), particularly among medical trainees, has seen a growth in programming that brings participants from high-income countries to low and middle-income settings in order to engage in service, teaching or research activities. Historically the domain of faith-based organizations conducting “missions”, STEGH are now offered by diverse groups including academic institutions, non-profit organizations, and the private sector, either as dedicated for-profits or through corporate social responsibility arms…

Health Economics, Policy and Law :: SPECIAL ISSUE: Frontiers of Health Policy Research

Health Economics, Policy and Law 
Volume 14 – Special Issue 2 – April 2019
https://www.cambridge.org/core/journals/health-economics-policy-and-law/latest-issue
SPECIAL ISSUE: Frontiers of Health Policy Research

If the enhancement of human freedom is both the main object and the primary means to development (Sen, 1999), then good individual and population health are both ends and means to development and freedom in all countries, regardless of their current ranking on the Human Development Index or other indexes on wealth, prosperity and well-being…

This special issue on the ‘frontiers in health policy research’ focuses attention on three distinct areas of inquiry. One set of papers analyses efforts to improve the quality of care and increase the value of care that health systems purchase. A second set of articles focuses on issues of health behaviour and social determinants of health. Finally, the third set of articles presents differing views on how to predict the adequacy of supply of medical professionals. The range of these articles illustrates, not only the exciting breadth of health policy research, but the degree to which scholars within this field are addressing issues of high importance to policy makers around the world. We think it is fair to claim that all of the articles address issues that are on the ‘frontier’ of health policy in the sense that they attempt to provide answers to questions that policy makers around the world are currently grappling with…

 

Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article Commentary
Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness
Heidi J Larson, Kenneth Hartigan-Go & Alexandre de Figueiredo
Pages: 625-627
Published online: 12 Oct 2018 Article

Regarding response by Dans et. al. to our article, “Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness.”

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Regarding response by Dans et. al. to our article, “Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness.”
Heidi Larson, Kenneth Hartigan-Go & Alexandre de Figueiredo
Page: 630
Published online: 19 Feb 2019

Empathy in vaccination counselling: a survey on the impact of a three-day residential course

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Empathy in vaccination counselling: a survey on the impact of a three-day residential course
Massimo Maurici, Michele Arigliani, Valentina Dugo, Carlo Leo, Valentina Pettinicchio, Raffaele Arigliani & Elisabetta Franco
Pages: 631-636
Published online: 15 Nov 2018

Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccines

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccines
Ozlem Equils, Caitlyn Kellogg, Lucy Baden, Wendy Berger & Shannon Connolly
Pages: 637-642
Published online: 29 Nov 2018

Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccines

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccines
Ozlem Equils, Caitlyn Kellogg, Lucy Baden, Wendy Berger & Shannon Connolly
Pages: 637-642
Published online: 29 Nov 2018

Knowledge, attitudes, behaviours, and beliefs of healthcare provider students regarding mandatory influenza vaccination

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Knowledge, attitudes, behaviours, and beliefs of healthcare provider students regarding mandatory influenza vaccination
Heba Ghandora, Donna M. Halperin, Jennifer E. Isenor, Beth A. Taylor, Philippe Fullsack, Antonia M. Di Castri & Scott A. Halperin
Pages: 700-709
Published online: 04 Jan 2019

Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak
Blair Capitano, Krista Dillon, Andre LeDuc, Bruce Atkinson & Cynthia Burman
Pages: 717-724
Published online: 08 Jan 2019

Impact of a vaccination promotion intervention using motivational interview techniques on long-term vaccine coverage: the PromoVac strategy

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 3, 2019
http://www.tandfonline.com/toc/khvi20/current

Article
Impact of a vaccination promotion intervention using motivational interview techniques on long-term vaccine coverage: the PromoVac strategy
Thomas Lemaitre, Nathalie Carrier, Anne Farrands, Virginie Gosselin, Geneviève Petit & Arnaud Gagneur
Pages: 732-739
Published online: 04 Jan 2019

Precision public health—the Emperor’s new clothes

International Journal of Epidemiology
Volume 48, Issue 1, February 2019
https://academic.oup.com/ije/issue/48/1

Opinion
Precision public health—the Emperor’s new clothes
David Taylor-Robinson; Frank Kee
International Journal of Epidemiology, Volume 48, Issue 1, February 2019, Pages 1–6, https://doi.org/10.1093/ije/dyy184
Extract
Recently the Centre for Disease Control suggested that ‘precision public health’ presents significant opportunities to improve the health of the population,1 but what does this concept add and does it live up to the hype? The promise is that by harnessing the power of Big Data, particularly genomic data, we may indeed see early gains in public health as a result of ‘more-accurate methods for measuring disease, pathogens, exposures, behaviors, and susceptibility’ to guide targeted prevention strategies.2 However, the term ‘precision public health’ is susceptible to misinterpretation.

 

Current and Future Challenges for Children Across the World

JAMA
April 2, 2019, Vol 321, No. 13, Pages 1229-1320
http://jama.jamanetwork.com/issue.aspx

Viewpoint
Current and Future Challenges for Children Across the World
Zulfiqar A. Bhutta, MBBS, FRCPCH, PhD; Robert E. Black, MD, MPH
free access
JAMA. 2019;321(13):1251-1252. doi:10.1001/jama.2019.1840
This Viewpoint argues that children have been left behind in UN and other global health efforts, calls for a focus on health measures beyond survival to define success, and outlines requirements to achieve real improvements in child health, including access to preventive care, a focus on education and nutrition, and introduction of information systems to monitor the population effects of health services.

[See Milestones above for full text]

 

Challenges in Early Childhood Development

JAMA Pediatrics
April 2019, Vol 173, No. 4, Pages 303-404
http://archpedi.jamanetwork.com/issue.aspx

Viewpoint
Challenges in Early Childhood Development
Kemin Qi, MD
JAMA Pediatr. 2019;173(4):307-308. doi:10.1001/jamapediatrics.2018.5381
This Viewpoint describes the significance of early childhood development (ECD) and the global challenges many clinicans face and proposes approaches and objectives for governments to reach to scale up ECD.

Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children

JAMA Pediatrics
April 2019, Vol 173, No. 4, Pages 303-404
http://archpedi.jamanetwork.com/issue.aspx

Original Investigation
Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children
Naïm Ouldali, MD; Corinne Levy, MD; Philippe Minodier, MD; et al.
JAMA Pediatr. 2019;173(4):362-370. doi:10.1001/jamapediatrics.2018.5273
This time-series analysis of community-acquired pneumonia diagnosed in 8 pediatric emergency departments in France assesses the rate of infection in children 15 years and younger before and after implement of a 13-valent pneumococcal conjugate vaccine.

Human mobility and health in a warming world

Journal of Travel Medicine
Volume 26, Issue 1, 2019
https://academic.oup.com/jtm/issue/26/1

Perspectives
Human mobility and health in a warming world
Patricia Nayna Schwerdtle, MPH, RN; Kathryn Bowen, PhD, MSc; Celia McMichael, PhD, MSc; Rainer Sauerborn, MD, PhD, MPH, MSc
Journal of Travel Medicine, Volume 26, Issue 1, 2019, tay160, https://doi.org/10.1093/jtm/tay160
Climate change will shape patterns of human mobility on a spectrum of voluntary migration to forced displacement. This paper discusses the nexus between climate change, migration and health, identifies climate hotspots and explores the health implications for climate-related migration.

Massive diphtheria outbreak among Rohingya refugees: lessons learnt

Journal of Travel Medicine
Volume 26, Issue 1, 2019
https://academic.oup.com/jtm/issue/26/1

Massive diphtheria outbreak among Rohingya refugees: lessons learnt
Md Ridwanur Rahman, MBBS, FCPS; Khaleda Islam, MBBS, MPH
Journal of Travel Medicine, Volume 26, Issue 1, 2019, tay122, https://doi.org/10.1093/jtm/tay122
Several lessons can be learnt from the massive diphtheria outbreak faced by Rohingya (forcibly displaced Myanmar nationals) refugees who fled violence in Myanmar and settled in camps and makeshift settlements in Cox’s Bazar, Bangladesh, 2017–2018.

China’s research renaissance

The Lancet
Apr 06, 2019   Volume 393Number 10179p1385-1476, e36
https://www.thelancet.com/journals/lancet/issue/current

Editorial
China’s research renaissance
The Lancet
   … An outward-looking China could broaden the influence of its scientific renaissance by fostering synergy between health researchers at home and abroad. In this way, the country’s research impact would be maximised. When researchers across countries embrace a collegial approach, advances in care anywhere are more likely to improve outcomes everywhere.

Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic

Nature Medicine
Volume 25 Issue 4, April 2019
https://www.nature.com/nm/volumes/25/issues/4

Review Article | 01 April 2019
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Broadly neutralizing antibodies have the potential to clear HIV and prevent further infection, as shown in emerging clinical studies.
Marina Caskey, Florian Klein & Michel C. Nussenzweig

Pharmacologic Research in Pregnant Women — Time to Get It Right

New England Journal of Medicine
April 4, 2019   Vol. 380 No. 14
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Pharmacologic Research in Pregnant Women — Time to Get It Right
Ahizechukwu C. Eke, M.D., M.P.H.,
Kelly E. Dooley, M.D., Ph.D.,
and Jeanne S. Sheffield, M.D.
Facilitating inclusion of pregnant women in clinical research could help answer important questions about the effects of medication use during pregnancy and the ways in which pregnancy alters pharmacokinetics and drug effects.

An Epidemic of Suspicion — Ebola and Violence in the DRC

New England Journal of Medicine
April 4, 2019   Vol. 380 No. 14
http://www.nejm.org/toc/nejm/medical-journal

Perspective
An Epidemic of Suspicion — Ebola and Violence in the DRC
Vinh-Kim Nguyen, M.D.
[Excerpts]
… As a medical team leader for Médecins sans Frontières (MSF), I work halfway between Butembo and Goma, North Kivu’s capital city and a transport hub.
…The community outreach workers I supervise have reported that in areas where security forces accompany Ebola teams, there is substantial distrust and palpable fear, most notably of forced vaccination. In areas where the epidemic response has not involved security forces, the opposite is true: people ask to be vaccinated. The lesson is clear: guns and public health don’t mix. Epidemics thrive on fear — when they are frightened, patients flee hospitals, sick people stay away to begin with, and affected communities distrust groups trying to respond to the epidemic.
As they see Land Rovers emblazoned with the logos of nongovernmental and international organizations cruising by, people in the DRC say, “Ebola is just a business.” They note that no one seems to care about daily deaths from malaria and other infectious diseases, the lack of clean water, or surgeries that must be performed by candlelight because there’s no power. “You will leave when Ebola does,” I have heard, “but we will still be here, slowly dying from the diseases that have always killed us.”…
…The mistrust of authority in the DRC also reflects a growing global mistrust of experts and science. Vaccine refusals are a growing problem worldwide, and they have already resulted in measles epidemics in the United States and France and in outbreaks elsewhere. Mistrust of public health authorities may thus be the new norm, and smoldering epidemics merely a symptom. State-of-the-art medical interventions won’t be enough without serious efforts to rebuild trust, informed by social science rather than pious liturgies. Displays of armed force feed a vicious cycle of mistrust, infection, and violence. If we continue down that path, those seemingly fantastical dystopian outbreak movies, with their heavily armed global health forces and rebelling populations, may not be so far from reality in the near future.

The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality

Pharmaceutics
Volume 11, Issue 3 (March 2019)
https://www.mdpi.com/1999-4923/11/3

Open Access  Review
The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality
by Maisa R. P. Araújo, Livia L. Sa-Barreto, Tais Gratieri, Guilherme M. Gelfuso and Marcilio Cunha-Filho
Pharmaceutics 2019, 11(3), 128; https://doi.org/10.3390/pharmaceutics11030128
Received: 24 February 2019 / Revised: 12 March 2019 / Accepted: 14 March 2019 / Published: 19 March 2019
Abstract
The pharmaceutical industry is set to join the fourth industrial revolution with the 3D printing of medicines. The application of 3D printers in compounding pharmacies will turn them into digital pharmacies, wrapping up the telemedicine care cycle and definitively modifying the pharmacotherapeutic treatment of patients. Fused deposition modeling 3D printing technology melts extruded drug-loaded filaments into any dosage form; and allows the obtainment of flexible dosages with different shapes, multiple active pharmaceutical ingredients and modulated drug release kinetics—in other words, offering customized medicine. This work aimed to present an update on this technology, discussing its challenges. The co-participation of the pharmaceutical industry and compounding pharmacies seems to be the best way to turn this technology into reality. The pharmaceutical industry can produce drug-loaded filaments on a large scale with the necessary quality and safety guarantees; while digital pharmacies can transform the filaments into personalized medicine according to specific prescriptions. For this to occur, adaptations in commercial 3D printers will need to meet health requirements for drug products preparation, and it will be necessary to make advances in regulatory gaps and discussions on patent protection. Thus, despite the conservatism of the sector, 3D drug printing has the potential to become the biggest technological leap ever seen in the pharmaceutical segment, and according to the most optimistic prognostics, it will soon be within reach.

A whole-health–economy approach to antimicrobial stewardship: Analysis of current models and future direction

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 6 Apr 2019)

Policy Forum
A whole-health–economy approach to antimicrobial stewardship: Analysis of current models and future direction
Monsey McLeod, Raheelah Ahmad, Nada Atef Shebl, Christianne Micallef, Fiona Sim, Alison Holmes
Policy Forum | published 29 Mar 2019 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1002774

Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences

PLoS One
http://www.plosone.org/
[Accessed 6 Apr 2019]

Research Article
Hepatitis B vaccination status and associated factors among undergraduate students of Makerere University College of Health Sciences
Yvette Wibabara, Cecily Banura, Joan Kalyango, Charles Karamagi, Alex Kityamuwesi, Winfred Christine Amia, Ponsiano Ocama
Research Article | published 05 Apr 2019 PLOS ONE
https://doi.org/10.1371/journal.pone.0214732

Evaluating Complex Health Interventions With Randomized Controlled Trials: How Do We Improve the Use of Qualitative Methods?

Qualitative Health Research
Volume 29 Issue 5, April 2019
http://qhr.sagepub.com/content/current

Special Issue: Qualitative Contributions to Randomized Control Trials
Guest Editorial
Evaluating Complex Health Interventions With Randomized Controlled Trials: How Do We Improve the Use of Qualitative Methods?
Jenevieve Mannell, Katy Davis
First Published March 14, 2019; pp. 623–631
Preview
Qualitative methods are underutilized in health intervention evaluation, and overshadowed by the importance placed on randomized controlled trials (RCTs). This Commentary describes how innovative qualitative methods are being used as part of RCTs, drawing on articles included in a special issue of Qualitative Health Research on this topic. The articles’ insights and a review of innovative qualitative methods described in trial protocols highlights a lack of attention to structural inequalities as a causal mechanism for understanding human behavior. We situate this gap within some well-known constraints of RCT methodologies, and a discussion of alternative RCT approaches that hold promise for bringing qualitative methods center stage in intervention evaluation, including adaptive designs, pragmatic trials, and realist RCTs. To address the power hierarchies of health evaluation research, however, we argue that a fundamental shift needs to take place away from a focus on RCTs and toward studies of health interventions.

Parental Experiences of Child Participation in a Phase I Pediatric Oncology Clinical Trial: “We Don’t Have Time to Waste”

Qualitative Health Research
Volume 29 Issue 5, April 2019
http://qhr.sagepub.com/content/current
Special Issue: Qualitative Contributions to Randomized Control Trials

Special Issue Articles
Parental Experiences of Child Participation in a Phase I Pediatric Oncology Clinical Trial: “We Don’t Have Time to Waste”
Stacey Crane, Joan E. Haase, Susan E. Hickman
First Published April 11, 2018; pp. 632–644
Abstract
Children with cancer are only eligible for phase I clinical trials (P1Ts) when no known curative therapy remains. However, the primary aims of P1Ts are not focused on directly benefiting participants. This raises ethical concerns that can be best evaluated by exploring the experiences of participants. An empirical phenomenology study, using an adapted Colaizzi method, was conducted of 11 parents’ lived experiences of their child’s participation in a pediatric oncology P1T. Study findings were that parents’ experiences reflected what it meant to have a child fighting to survive high-risk cancer. Although elements specific to P1T participation were identified, more pervasive was parents’ sense of running out of time to find an effective treatment and needing to use time they had with their child well. Even though some problems were identified, overall parents did not regret their child’s P1T participation and would recommend P1Ts to other parents of children with cancer.

The attitude of scholars has not changed towards plagiarism since the medieval period: Definition of plagiarism according to Shams-e-Qays, thirteenth-century Persian literary scientist

Research Ethics
Volume 15 Issue 2, April 2019
http://journals.sagepub.com/toc/reab/current

Topic Piece
The attitude of scholars has not changed towards plagiarism since the medieval period: Definition of plagiarism according to Shams-e-Qays, thirteenth-century Persian literary scientist
Ramin Sadeghi
First Published May 31, 2016; pp. 1–3
Abstract
Almost all researchers are familiar with the concept of plagiarism these days. However, many scholars allege that plagiarism and its ethical ramifications are new western concepts that have not existed in scientific and literary history. In their opinion, using the ideas of others was allowed liberally in past academic and literary communities. I have presented the definition of “plagiarism” according to Shams-e-Qays, a great Persian literary scientist of the thirteenth century AD, to show that this is not the case and that the attitude towards plagiarism was even more strict in ancient times.

 

Reaping the Benefits and Avoiding the Risks: Unrealistic Optimism in the Health Domain

Risk Analysis          
Volume 39, Issue 4  Pages: 741-956  April 2019
https://onlinelibrary.wiley.com/toc/15396924/current

Original Research Article
Reaping the Benefits and Avoiding the Risks: Unrealistic Optimism in the Health Domain
Yaniv Hanoch, Jonathan Rolison, Alexandra M. Freund
Pages: 792-804
First Published: 04 October 2018
Abstract
People’s perceptions of benefits and risks play a key role in their acceptance or rejection of medical interventions, yet these perceptions may be poorly calibrated. This online study with N = 373 adults aged 19–76 years focused on unrealistic optimism in the health domain. Participants indicated how likely they were to experience benefits and risks associated with medical conditions and completed objective and subjective numeracy scales. Participants exhibited optimistic views about the likelihood of experiencing the benefits and the side effects of treatment options described in the scenarios. Objective and subjective numeracy were not associated with more accurate ratings. Moreover, participants’ underestimation of the risks was significantly greater than their overestimation of the benefits. From an applied perspective, these results suggest that clinicians may need to ensure that patients do not underestimate risks of medical interventions, and that they convey realistic expectations about the benefits that can be obtained with certain procedures.

The challenge of antimicrobial resistance: What economics can contribute

Science         
05 April 2019  Vol 364, Issue 6435
http://www.sciencemag.org/current.dtl

Review
The challenge of antimicrobial resistance: What economics can contribute
By Laurence S. J. Roope, Richard D. Smith, Koen B. Pouwels, James Buchanan, Lucy Abel, Peter Eibich, Christopher C. Butler, Pui San Tan, A. Sarah Walker, Julie V. Robotham, Sarah Wordsworth
Science05 Apr 2019
Incentivizing restraint in drug use
The accelerating tide of antimicrobial resistance (AMR) is a major worldwide policy concern. Like climate change, the incentives for individual decision-makers do not take into account the costs to society at large. AMR represents an impending “tragedy of the commons,” and there is an immediate need for collective action to prevent future harm. Roope et al. review the issues associated with AMR from an economics perspective and draw parallels with climate change. A major stumbling block for both challenges is to build consensus about the best way forward when faced with many uncertainties and inequities.

Abstract
As antibiotic consumption grows, bacteria are becoming increasingly resistant to treatment. Antibiotic resistance undermines much of modern health care, which relies on access to effective antibiotics to prevent and treat infections associated with routine medical procedures. The resulting challenges have much in common with those posed by climate change, which economists have responded to with research that has informed and shaped public policy. Drawing on economic concepts such as externalities and the principal–agent relationship, we suggest how economics can help to solve the challenges arising from increasing resistance to antibiotics. We discuss solutions to the key economic issues, from incentivizing the development of effective new antibiotics to improving antibiotic stewardship through financial mechanisms and regulation.

 

 

Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review

Travel Medicine and Infectious Diseases
Volume 28  Pages 1-120 (March–April 2019)
http://www.travelmedicinejournal.com/

Review article  Abstract only
Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review
Samir Benkouiten, Jaffar A. Al-Tawfiq, Ziad A. Memish, Ali Albarrak, Philippe Gautret
Pages 15-26

Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation

Vaccine
Volume 37, Issue 16 Pages 2167-2284 (10 April 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/16

Discussion  No access
Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation
Gregory A. Poland, Laura Lee Hall, Jennifer A. Powell, for the Advisory Group Meeting “Influenza Immunization among Older Adults: Population Health Strategies for Promoting Equity and Achieving Healthy People 2020 Goals ”
Pages 2167-2170

Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus – Zaire Ebolavirus Vaccine

Vaccine
Volume 37, Issue 16 Pages 2167-2284 (10 April 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/16

Short communication  Abstract only
Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus – Zaire Ebolavirus Vaccine
Masumbuko Claude Kasereka, Julia Sawatzky, Michael T. Hawkes
Pages 2174-2178

Comparison of early childhood vaccination coverage and timeliness between children born to Italian women and those born to foreign women residing in Italy: A multi-centre retrospective cohort study

Vaccine
Volume 37, Issue 16 Pages 2167-2284 (10 April 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/16

Research article  Abstract only
Comparison of early childhood vaccination coverage and timeliness between children born to Italian women and those born to foreign women residing in Italy: A multi-centre retrospective cohort study
Massimo Fabiani, Valeria Fano, Teresa Spadea, Cinzia Piovesan, … Patrizio Pezzotti
Pages 2179-2187

It’s not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook

Vaccine
Volume 37, Issue 16 Pages 2167-2284 (10 April 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/16

Research article  Full text access
It’s not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook
Beth L. Hoffman, Elizabeth M. Felter, Kar-Hai Chu, Ariel Shensa, … Brian A. Primack
Pages 2216-2223

Caregiver’s attitudes, beliefs, and experiences for influenza vaccination in Australian children with medical comorbidities

Vaccine
Volume 37, Issue 16 Pages 2167-2284 (10 April 2019)
https://www.sciencedirect.com/journal/vaccine/vol/37/issue/16

Research article  Abstract only
Caregiver’s attitudes, beliefs, and experiences for influenza vaccination in Australian children with medical comorbidities
Daniel A. Norman, Margie Danchin, Paul Van Buynder, Hannah C. Moore, … Holly Seale
Pages 2244-2248

Media/Policy Watch

Media/Policy Watch

This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.

We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
 
 
The Atlantic
http://www.theatlantic.com/magazine/
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
BBC
http://www.bbc.co.uk/
Accessed 6 Apr 2019
Published Date
4 Apr 2019
HPV vaccine linked to ‘dramatic’ drop in cervical disease
…The routine vaccination of girls with the HPV vaccine in Scotland…
 
 
Devex
https://www.devex.com/news
Accessed 6 Apr 2019
Global Views / Global health
Opinion: It’s time to rebuild public confidence in vaccines
By Heidi Larson // 03 April 2019
…However, the answer to combating today’s currents of vaccine dissent is far more complex than addressing the needed technical fixes and must be part of a wider effort involving multiple partners, including citizens. If the moves of tech companies are perceived as censorship, they may only harden the views of those who feel they already have no voice…
 
 
The Economist
http://www.economist.com/
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
Financial Times
http://www.ft.com/home/uk
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
Forbes
http://www.forbes.com/
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
Foreign Affairs
http://www.foreignaffairs.com/
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
Foreign Policy
http://foreignpolicy.com/
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
The Guardian
http://www.guardiannews.com/
Accessed 6 Apr 2019
Vaccines and immunisation
‘Sentencing their dog to death’: how the anti-vax movement spread to pets
There has been a spike in people refusing to vaccinate pets against deadly diseases, including some that can infect humans
Michael McGowan
Sat 6 Apr 2019 00.52 EDT
 
 
New Yorker
http://www.newyorker.com/
Accessed 6 Apr 2019
[No new, unique, relevant content]
 
 
New York Times
http://www.nytimes.com/
Accessed 6 Apr 2019
Opinion
Parenting in the Time of Measles
As many as half of the home-schooled kids I encounter are not vaccinated.
By Bethany Mandel
Ms. Mandel, who home-schools her children, is a part-time editor at Ricochet.
April 3, 2019

Health
Scientists Thought They Had Measles Cornered. They Were Wrong.
Following intensive vaccination efforts, measles cases plunged across the world. Now clusters of new infections — some linked, some not — have confounded health officials.
April 3, 2019

U.S.
Kentucky Judge Rules Against Unvaccinated Student in Lawsuit
A Kentucky judge has ruled against a student who sued after he wasn’t allowed to play basketball because he wasn’t vaccinated for chickenpox.
April 2, 2019

Scientific American
https://www.scientificamerican.com/
Accessed 6 Apr 2019
April 2019
How the World’s First Dengue Vaccination Drive Ended in Disaster
Is a runaway immune reaction making a dengue vaccine dangerous?

Wall Street Journal
http://online.wsj.com/home-page?_wsjregion=na,us&_homepage=/home/us
Accessed 6 Apr 2019
Letters
Dealing With Measles Vaccination Deniers
23 hours ago
Perhaps if we stop worrying about our political agendas and concentrate on the health of our children, we will no longer read headlines about children needlessly being infected with preventable illnesses…

 

Washington Post
http://www.washingtonpost.com/
Vaccine wars: Social media battle outbreak of bogus claims
Barbara Ortutay | AP · Business · Apr 5, 2019

Think Tanks et al

Think Tanks et al

 

Brookings
http://www.brookings.edu/
Accessed 6 Apr 2019
[No new relevant content]

Center for Global Development  
http://www.cgdev.org/page/press-center
4/3/19
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? It Depends
Publication
Is price transparency really the answer to healthcare systems’ fiscal sustainability challenges as they strive to expand access to new technologies or even merely sustain provision within strained public budgets? Well, it depends!
Pdf: https://www.cgdev.org/sites/default/files/can-transparency-lower-prices-and-improve-access-pharmaceuticals-it-depends.pdf

CSIS
https://www.csis.org/
Accessed 6 Apr 2019
[No new relevant content]

Council on Foreign Relations
http://www.cfr.org/
Accessed 6 Apr 2019
April 4, 2019
Mozambique
Cyclone Idai Reveals Africa’s Vulnerabilities
Floodwaters in Mozambique could spread cholera, raising the death toll even after the storm has passed.
by Laura Hillard

 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 6 Apr 2019
[No new relevant content]

Vaccines and Global Health: The Week in Review :: 30 March 2019

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

 pdf version A pdf of the current issue is available here: Vaccines and Global Health_The Week in Review_30 Mar 2019

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

WHO – SAGE [Strategic Advisory Group of Experts] Meeting

Milestones :: Perspectives

WHO – SAGE [Strategic Advisory Group of Experts] Meeting
The next SAGE meeting will take place in Geneva from the 2-4 April 2019.
Draft agenda for SAGE April 2019 meeting  pdf, 76kb  [As of 25 March 2019]

Selected Agenda Items
:: Quality and Use of Immunization and Surveillance Data
:: Report from the Global Advisory Committee on Vaccine Safety (GACVS) meeting 5-6 December 2018
:: Update on the development of a Post-2020 Immunization Strategy
:: Malaria Vaccine
:: Polio the last mile
:: Meningococcal vaccines: Global Strategy
:: Ebola vaccines
:: Update on the SAGE Evaluation

Polio Eradication

Milestones :: Perspectives

Polio Eradication

Dr Tedros Adhanom Ghebreyesus, WHO Director-General and Chair of the Polio Oversight Board, issued a personal response [first text below] to the joint statement published in January by the Chairs of the main, independent, advisory and oversight committees of the GPEI [second text below].

March 2019
Dear Chairs of the GCC, IHR Emergency Committee, 1MB and SAGE,
On behalf of the Global Polio Eradication Initiative (OPEi) and as current Chair of the Polio Oversight Board, I would like to thank you for your recently-published joint communique on the polio eradication effort. Your assessment of the current global situation, and what needs to happen to achieve success, is as accurate as it is motivating. Thank you for this strong call for action.

Let me assure you: all partners of the OPEi fully agree with you.

As a global community, we have been engaged in this fight for 31 years now. Wild poliovirus cases now persist in only a handful of districts of just two countries – Pakistan and Afghanistan.

In January, I was joined by Dr Al Mandhari, Regional Director for the Eastern Mediterranean, and Dr Chris Elias, President of the Global Development Division at the Bill & Melinda Gates Foundation, as we visited both countries where we witnessed first-hand the tremendous efforts being undertaken to interrupt the remaining chains of wild polio transmission there. I have rarely been so impressed by public health efforts being undertaken as in these two areas, as both countries work hand-in-hand to tackle this joint epidemiological block, as both countries engage and mobilise all levels of public and civil society to support this effort.

As you rightly point out, eradication is an “all-or-nothing” approach. We either eradicate, or we do not. And the truth is, everything in place for success to be achieved. The Endgame Plan through 2013-2018 has brought us to the brink of being polio-free. And the Strategic Plan 2019-2023 aims to build on the lessons learned since 2013. Its aim is to increase performance everywhere, including using the proven tools of eradication and building blocks that have been established, while using opportunities to innovate using local knowledge and insights to overcome obstacles that in the past have seemed insurmountable. The key is to optimise all these approaches, and if the Plan is fully financed and implemented at all levels, a lasting polio-free world will be secured for all future generations to come.

That is why I commit to you today: we will rise to your call to action, and we will excel in our jobs, and this will lead to the success we all want to see. As you challenge us, we commit to making it our overriding objective to find and reach that last unvaccinated child before the poliovirus does. We will give the poliovirus nowhere to hide.

Your continued guidance, independent assessments and oversight will be critical to help us in securing this success. It is this guidance which has been instrumental in helping bring us to the threshold of a polio-free world, and it will be your continued guidance which will help us finally cross this threshold. Please continue with your assessments. Continue to critically evaluate what we are doing. Continue to issue your joint statements to draw attention to what needs to be done. We must have this oversight.

On behalf of our partners at Rotary International, the US Centers for Disease Control and Prevention (CDC), UNICEF, the Bill & Melinda Gates Foundation, and mostly on behalf of the children of the world, thank you!

Dr Tedros Ghebreyesus
Director-General, World Health Organization
Chair, Polio Oversight Board of the Global Polio Eradication Initiative

::::::

 

January 2019
Dear Polio Eradicator,

The global polio eradication effort is 31 years old.

The world is tantalizingly close to being free of polio. From 350,000 wild poliovirus cases every year in 1988, in 2018 the world reported just 29 cases of this devastating disabling disease because of extraordinary global efforts. Wild poliovirus transmission is endemic in only a handful of districts worldwide. The aim of the 2013-2018 Endgame Plan had been to be finished with this job by end 2018. This is not the case, and the Plan has to now be revised and extended through 2023.

This is an effort that cannot be sustained indefinitely: 31 years is long enough. It is resource intensive. It is intensive on the countries affected. It is intensive on donors. It is intensive on health services. It is intensive on communities. Most of all, it is intensive on those children and their families who bear the burden of this terrible disease, needlessly.

There is no reason why polio should persist anywhere in the world.

To succeed by 2023, all involved in this effort must find ways to excel in their roles. If this happens, success will follow.

This means stepping up the level of performance even further. It means using the proven tools of eradication and building blocks that have been established in parts of the world that have been free of polio for years. The vaccines, the cold chains, the networks of vaccinators, the surveillance capacity, the governance, policy, financing and oversight structures must be at peak levels of performance. There must be an unrelenting focus to tighten the management of the effort at all levels.

It also means looking for opportunities to innovate, using local knowledge and insights to overcome obstacles that in the past have seemed insurmountable. It means looking at new and different ways to reach children. It means really understanding the views of parents, and communities, who are unwilling to accept the vaccine and finding ways to address their concerns and come together with them. It means more effectively engaging with communities and better serving their needs than we have been doing thus far. Each person must dedicate themselves to one clear objective – to reach that very last child with polio vaccine.

Please commit to finding that very last child first, before the poliovirus does. Give the poliovirus nowhere to hide.

Whatever barrier to reaching that very last child, the programme has the expertise and experience to overcome it. Let everyone perfect what we know works. Let everyone free their mind to come up with new ideas and transformative solutions. We must all treat this as the public health emergency that it is.

As a global community, we have stood before where we stand today, with smallpox. The scourge of smallpox is gone, for which the world is a much better place. Let us make history again. It is time to finish the job of polio eradication now. The philosopher, poet and essayist Ralph Waldo Emerson said: “To leave the world a bit better, whether by a healthy child, a garden patch or a redeemed social condition, to know even one life has breathed easier because you have lived – this is to have succeeded.”

Eradicate polio, and make the world a better place for future generations.

Thank you.

Professor Alejandro Cravioto
   Chair of the Strategic Advisory Group of Experts on immunization (SAGE)

Sir Liam Donaldson
   Chair of the Independent Monitoring Board (IMB) of the Global Polio Eradication Initiative

Professor Helen Rees
   Chair of the Emergency Committee of the International Health Regulations (IHR) Regarding
      the International Spread of Poliovirus

Professor David Salisbury
   Chair of the Global Commission for the Certification of the Eradication of Poliomyelitis (GCC)